Paul F Truex is Director of Milestone Pharmaceuticals Inc.. Currently has a direct ownership of 81,780 shares of MIST, which is worth approximately $146,386. The most recent transaction as insider was on May 31, 2022, when has been sold 5,000 shares (Common Shares) at a price of $5.6 per share, resulting in proceeds of $28,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.8K
0% 3M change
0% 12M change
Total Value Held $146,386

PAUL F TRUEX Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2022
BUY
Open market or private purchase
$28,000 $5.6 p/Share
5,000 Added 5.76%
81,780 Common Shares
May 31 2022
BUY
Exercise of conversion of derivative security
$132,062 $1.72 p/Share
76,780 Added 50.0%
76,780 Common Shares

Also insider at

CBAY
CymaBay Therapeutics, Inc. Healthcare
PFT

Paul F Truex

Director
Newark, CA

Track Institutional and Insider Activities on MIST

Follow Milestone Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIST shares.

Notify only if

Insider Trading

Get notified when an Milestone Pharmaceuticals Inc. insider buys or sells MIST shares.

Notify only if

News

Receive news related to Milestone Pharmaceuticals Inc.

Track Activities on MIST